Lista de obras -

A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.

artículo científico publicado en 2016

A ceramide-centric view of insulin resistance ⬇️

artículo científico publicado el 2 de mayo de 2012

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

artículo científico publicado en 2003

Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice

artículo científico publicado en 2008

Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling ⬇️

artículo científico publicado el 1 de abril de 2013

Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro ⬇️

artículo científico publicado el 11 de septiembre de 2012

Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling

artículo científico publicado en 2005

Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism.

artículo científico publicado en 2016

Assaying AKT/protein kinase B activity

artículo científico publicado en 2003

Autophagy Ablation in Adipocytes Induces Insulin Resistance and Reveals Roles for Lipid Peroxide and Nrf2 Signaling in Adipose-Liver Crosstalk

scientific article published on 01 November 2018

Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans

artículo científico publicado en 2002

Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.

artículo científico publicado en 2014

Ceramides - Lipotoxic Inducers of Metabolic Disorders: (Trends in Endocrinology and Metabolism 26, 538-550; 2015).

artículo científico publicado en 2017

Ceramides and glucosylceramides are independent antagonists of insulin action

artículo científico publicado en 2012

Ceramides and glucosylceramides are independent antagonists of insulin signaling

artículo científico publicado en 2013

Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes

artículo científico publicado en 2020

Ceramides as modulators of cellular and whole-body metabolism

artículo científico publicado en 2011

Ceramides: Nutrient Signals that Drive Hepatosteatosis

scientific article published on 13 November 2019

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes ⬇️

artículo científico publicado el 15 de noviembre de 2003

Conditional deletion of Des1 in the mouse retina does not impair the visual cycle in cones

scientific article published on 15 January 2019

Could Ceramides Become the New Cholesterol?

artículo científico publicado en 2017

DES1: A Key Driver of Lipotoxicity in Metabolic Disease

artículo científico publicado en 2020

Dihydroceramides: From Bit Players to Lead Actors

artículo científico publicado en 2015

Does This Schlank Make Me Look Fat?

artículo científico publicado en 2018

Effect of a membrane-targeted sphingosine kinase 1 on cell proliferation and survival.

artículo científico publicado en 2005

Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans

artículo científico publicado en 2013

Fat-cell mass, serum leptin and adiponectin changes during weight gain and loss in yellow-bellied marmots (Marmota flaviventris).

artículo científico publicado en 2004

Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis ⬇️

artículo científico publicado el 2 de abril de 2012

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

artículo científico publicado en 2007

Lipid mediators of insulin resistance

artículo científico publicado en 2007

Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice

artículo científico publicado en 2011

Listen to your heart when ceramide's calling for higher glucose

article

Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease

scientific article published on 01 March 2020

Measuring insulin-stimulated phosphatidyl-inositol 3-kinase activity

artículo científico publicado en 2003

Metabolic Messengers: ceramides

artículo científico publicado en 2019

Phospholipid methylation regulates muscle metabolic rate through Ca2+ transport efficiency

scientific article published on 16 September 2019

Physiological mechanisms of sustained fumagillin-induced weight loss.

artículo científico publicado en 2018

Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction

artículo científico publicado en 2018

Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.

artículo científico publicado en 2016

Rebuttal from Scott A. Summers and Bret H. Goodpaster

artículo científico publicado en 2016

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

artículo científico publicado en 2010

Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

artículo científico publicado en 2004

Risky lipids: refining the ceramide score that measures cardiovascular health

artículo científico publicado en 2020

Seasonal, tissue-specific regulation of Akt/protein kinase B and glycogen synthase in hibernators

artículo científico publicado en 2003

Sphingolipids and hepatic steatosis

artículo científico

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

artículo científico publicado en 2016

Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism

artículo científico publicado en 2008

Strong Heart, Low Ceramides

artículo científico publicado en 2018

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

artículo científico publicado en 2019

The ceramide ratio: a predictor of cardiometabolic risk

artículo científico publicado en 2018

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD

artículo científico publicado en 2020

Lista de obras de

A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.

A ceramide-centric view of insulin resistance ⬇️

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice

Ablation of Dihydroceramide Desaturase 1, a Therapeutic Target for the Treatment of Metabolic Diseases, Simultaneously Stimulates Anabolic and Catabolic Signaling ⬇️

Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro ⬇️

Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling

Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism.

Assaying AKT/protein kinase B activity

Autophagy Ablation in Adipocytes Induces Insulin Resistance and Reveals Roles for Lipid Peroxide and Nrf2 Signaling in Adipose-Liver Crosstalk

Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans

Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.

Ceramides - Lipotoxic Inducers of Metabolic Disorders: (Trends in Endocrinology and Metabolism 26, 538-550; 2015).

Ceramides and glucosylceramides are independent antagonists of insulin action

Ceramides and glucosylceramides are independent antagonists of insulin signaling

Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes

Ceramides as modulators of cellular and whole-body metabolism

Ceramides: Nutrient Signals that Drive Hepatosteatosis

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes ⬇️

Conditional deletion of Des1 in the mouse retina does not impair the visual cycle in cones

Could Ceramides Become the New Cholesterol?

DES1: A Key Driver of Lipotoxicity in Metabolic Disease

Dihydroceramides: From Bit Players to Lead Actors

Does This Schlank Make Me Look Fat?

Effect of a membrane-targeted sphingosine kinase 1 on cell proliferation and survival.

Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans

Fat-cell mass, serum leptin and adiponectin changes during weight gain and loss in yellow-bellied marmots (Marmota flaviventris).

Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis ⬇️

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

Lipid mediators of insulin resistance

Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice

Listen to your heart when ceramide's calling for higher glucose

Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease

Measuring insulin-stimulated phosphatidyl-inositol 3-kinase activity

Metabolic Messengers: ceramides

Phospholipid methylation regulates muscle metabolic rate through Ca2+ transport efficiency

Physiological mechanisms of sustained fumagillin-induced weight loss.

Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction

Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.

Rebuttal from Scott A. Summers and Bret H. Goodpaster

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

Risky lipids: refining the ceramide score that measures cardiovascular health

Seasonal, tissue-specific regulation of Akt/protein kinase B and glycogen synthase in hibernators

Sphingolipids and hepatic steatosis

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism

Strong Heart, Low Ceramides

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

The ceramide ratio: a predictor of cardiometabolic risk

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD